Type 5 Adenylyl Cyclase Disruption Alters Not Only
Sympathetic But Also Parasympathetic and Calcium-Mediated Cardiac Regulation C ardiac rate and contractility are regulated by both sympathetic and parasympathetic mechanisms. Sympathetic stimulation leads to coupling of the ␤-adrenergic receptor (␤-AR) and Gs, the G-protein responsible for stimulating activity of adenylyl cyclase (AC), a membrane-bound enzyme that catalyzes the conversion of ATP to cAMP, thereby stimulating protein kinase A and ultimately increasing cardiac contractility. [1] [2] [3] [4] Parasympathetic stimulation counteracts these effects through the activation of the muscarinic receptor and Gi, the G-protein that can inhibit cardiac contractility and rate. 5 These sympathetic and parasympathetic mechanisms constitute the two arms of autonomic regulation of the heart. A considerable amount of data exists relating to autonomic regulation at the level of their respective receptors and G-proteins. A novel concept to consider, central to this study, is whether parasympathetic regulation also occurs at the level of AC.
The goal of the present investigation was to determine the regulation of cardiac contraction and rate by type 5 AC in response to ␤-AR stimulation and also whether it can modulate parasympathetic function in vivo. Whereas all prior studies have examined these questions in vitro 6 or in vivo 7, 8 using pharmacological stimulation or even by overexpressing isoforms of AC in the heart, 9 -11 we selected the approach of targeted disruption of AC. However, this experimental design is complicated by the fact that AC consists of 9 mammalian transmembrane isoforms. 4, [12] [13] [14] We selected type 5 AC to knockout in the mouse (AC5 Ϫ/Ϫ ), because this isoform is one of the most prominent in adult cardiac tissue and is expressed negligibly in other organs except for the brain. 4, 15, 16 Furthermore, whereas all of the 9 AC isoforms so far isolated can be linked to Gs stimulation, Gi inhibition is associated with only a few AC isoforms, eg, types 1, 5, and 6 AC, and has been observed only in vitro. 17, 18 In addition, type 5 AC also is inhibited directly by low concentrations of calcium (Ca 2ϩ ). 19 Therefore, we also examined the regulation of AC activity by Ca 2ϩ . 20 The specific questions we addressed in this study are whether elimination of type 5 AC decreases either baseline cardiac function or heart rate (HR), impairs sympathetic stimulation, or alters parasympathetic modulation of cardiac function and HR. We addressed these questions using a combination of in vivo and in vitro approaches, eg, by measuring cardiac function echocardiographically, measuring HR in conscious mice, measuring Ca 2ϩ channel activity of isolated myocytes, and assessing AC activity in vitro in cardiac membranes.
Materials and Methods

Generation of Knockout Mice
All mice were 129/SvJ-C57BL/6 mixed-background littermates from F1 heterozygote crosses. All experiments were performed in 4-to 6-month-old homozygous AC5 Ϫ/Ϫ and wild-type (WT) littermates. This study was approved by the Animal Care and Use Committee at New Jersey Medical School (see the online supplement, available at http://www.circresaha.org, for additional detail).
RNase Protection Assay
Partial fragments of mouse AC cDNA clones for each isoform (types 1 through 9) were obtained by polymerase chain reaction. A human 28S ribosomal RNA probe was used as an internal control. RNase protection assay was performed using the RPA III kit (Ambion) as suggested by the manufacturer.
AC Assay
Hearts were dissected from the mice, and membrane preparations were prepared as described previously. 21 For the study of Ca 2ϩ inhibition, the membranes were treated first with EGTA to extract the endogenous Ca 2ϩ before the assay. Free Ca 2ϩ concentrations were obtained with the use of 200-mol/L EGTA buffers, as described previously. 22, 23 Physiological Studies ECG wires, a jugular vein catheter for drug infusion, and a femoral artery catheter for arterial pressure monitoring were implanted under anesthesia as described previously. 24, 25 Measurements of left ventricular ejection fraction (LVEF) were taken using echocardiography under anesthesia with 2.5% tribromoethanol (0.010 to 0.015 mL per gram of body weight) injected intraperitoneally. 26, 27 Intravenous infusion of ISO (0.04 g/kg per min IV for 5 minutes) was performed using an infusion pump. To examine the responses to a muscarinic agonist, acetylcholine (ACh) (25 mg/kg IP) was coadministered intraperitoneally during the intravenous infusion of ISO (0.04 g/kg per min). In addition, in conscious mice, ACh (0.01 and 0.05 mg/kg), atropine (0.25, 1, and 2 mg/kg), or verapamil (0.75 mg/kg) was administered intravenously, and the ECG was recorded. A recovery period of 15 minutes was allowed for the HR to return to baseline before administering the next drug. To examine HR responses to baroreflex hypertension, phenylephrine (0.2 mg/kg IV) was infused and the ECG and arterial pressure were measured.
Pathology
The pathological examination included assessment of body weight, heart weight, and light microscopy of H&E-stained sections of the left ventricle.
Radioligand Binding Assays and Western Blotting
Radioligand binding assays for ␤-AR were conducted using the above membrane preparations and 125 I-cyanopindolol as previously described. 28 Western blotting was conducted using commercially available antibodies, except for type 5 AC (see the online data supplement).
Electrophysiological Studies
Whole-cell currents were recorded using patch-clamp techniques as previously described. 29 -32 (See the online data supplement for additional detail.)
Statistical Analysis
All data are reported as meanϮSEM. Comparisons between AC5
and WT values were made using a Student's t test. For statistical analysis of data from multiple groups, one-way ANOVA was used with Bonferroni post hoc test. PϽ0.05 was taken as a minimal level of significance.
An expanded Materials and Methods section can be found in the online data supplement available at http://www.circresaha.org.
Results
Targeted Disruption of the Type 5 AC Gene
The type 5 AC gene was disrupted in mice using homologous recombination ( Figure 1A ). Mice were genotyped by Southern blotting using genomic DNA from tail biopsies ( Figure  1B ). mRNA expression of type 5 AC was undetectable in AC5 Ϫ/Ϫ ( Figure 1C ). Type 5 AC cardiac protein was undetectable in AC5 Ϫ/Ϫ ( Figure 1D ). The growth, general appearance, and heart size of the AC5 Ϫ/Ϫ were similar to WT (Table) . Normal cardiac architecture was demonstrated on light microscopy (see the online data supplement). Ϫ/Ϫ mouse heart compared with WT using type 5 AC-specific antibody.
No Compensatory Increase in the Other Isoforms of AC
We then examined whether there were compensatory increases in the expression of the other isoforms of AC in AC5 Ϫ/Ϫ . Because AC isoform-specific antibodies that can convincingly determine the level of protein expression of all the isoforms are not available, we quantitated the mRNA expression of the AC isoforms by RNase protection assays. cRNA of the 28S rRNA was used as an internal control. Type 2, 3, 4, 6, 7, and 9 AC were detected readily but not increased ( Figure 2 ), whereas types 1 and 8 were hardly detectable (data not shown), indicating that type 6 AC, a homologue of type 5 AC in the heart, could not compensate for the type 5 AC deficiency.
AC Activity Was Decreased in the Heart of AC5
؊/؊ In Vitro AC activity was decreased in AC5 Ϫ/Ϫ relative to that in WT by 35Ϯ4% (basal), 27Ϯ5% (ISO), 27Ϯ2% (GTP␥S), and 40Ϯ5% (forskolin) ( Figure 3A ). More specifically, ISO increased AC activity by 78Ϯ6 pmol/15 min per mg in WT but only 64Ϯ4 pmol/15 min per mg in AC5 Ϫ/Ϫ , indicating that the response to ISO was attenuated in AC5 Ϫ/Ϫ . These data indicate that type 5 AC is responsible for Ϸ30% to 40% of total AC activity in the mouse heart. Carbachol (10 mol/L), a muscarinic agonist, decreased ISO-stimulated AC activity by 21Ϯ3% in WT, but this was hardly detectable in AC5 Ϫ/Ϫ ( Figure 3B ), indicating that muscarinic (Gi-induced) inhibition of the AC activity is markedly attenuated in AC5 Ϫ/Ϫ .
Regulation of AC Activity by Free Ca
2؉
To investigate the modulation of AC activity by free Ca 2ϩ , we examined cAMP production in membranes from the hearts of WT and AC5
Ϫ/Ϫ at different Ca 2ϩ concentrations in the presence of ISO (100 mol/L ISOϩ100 mol/L GTP) ( Figure 3C ). The ISO-stimulated AC activity was inhibited by increasing concentrations of Ca 2ϩ as expected in WT. The Ca 2ϩ inhibition of AC activity was impaired in AC5 Ϫ/Ϫ . The reduction in magnitude of inhibition was most apparent in AC5 Ϫ/Ϫ , ie, in the submicromolar range of Ca 2ϩ ( Figure 3C ).
Basal Cardiac Function Was Not Decreased, but the Response to ISO and Muscarinic Inhibition of ISO Were Impaired
We originally hypothesized that cardiac function, both basal and ISO-stimulated, would be depressed in AC5 Ϫ/Ϫ . The cardiac responses to intravenous ISO on LVEF in AC5 Ϫ/Ϫ , 70Ϯ1.2% versus 70Ϯ1.5%, nϭ10 to 11; fractional shortening: WT versus AC5 Ϫ/Ϫ , 33Ϯ0.9% versus 33Ϯ1.0%, nϭ10 to 11) (Table) . Muscarinic inhibition of ISO-stimulated cardiac function, as measured by LVEF, was prominent in WT, as expected, but was attenuated Heart Size and Cardiac Function (Table) . The increase in HR after muscarinic receptor blockade by atropine (1 mg/kg IV) in WT was not observed in AC5 Ϫ/Ϫ ( Figure 5A ). Muscarinic stimulation in conscious WT with ACh (0.01 mg/kg IV) decreased HR by 15% but significantly less (1.3%) in AC5 Ϫ/Ϫ ( Figure 5B ). However, high doses of ACh (0.05 mg/kg IV) decreased HR similarly in both WT and AC5 Ϫ/Ϫ . At the higher doses of ACh, it is possible that the lack of AC5 inhibition was overwhelmed. In contrast, verapamil, which decreases HR through a nonmuscarinic mechanism, reduced HR in AC5 Ϫ/Ϫ and WT similarly (Ϫ33Ϯ10 versus Ϫ36Ϯ10 bpm). These findings suggest that muscarinic inhibition was impaired in the conscious state in the absence of ISO stimulation in AC5 Ϫ/Ϫ . To confirm that muscarinic, and therefore parasympathetic, neural regulation of the heart was changed, we injected phenylephrine (0.2 mg/kg IV) to elevate arterial pressure transiently through vasoconstriction and to induce baroreflex-mediated slowing of HR. Phenylephrine increased systolic arterial pressure similarly in both WT and AC5 Ϫ/Ϫ . However, the degree of HR slowing was significantly less in AC5 Ϫ/Ϫ than in WT ( Figure  5C ), suggesting that the baroreflex, most likely through its parasympathetic control, was attenuated in AC5 Ϫ/Ϫ . Figure 3 . Adrenergic, muscarinic, and Ca 2ϩ -mediated regulation of cardiac AC activity. A, AC activity in vitro. The steady-state AC activity was determined as the maximal cAMP production over 15 minutes. Stimulation was performed at the level of the ␤-AR (ISO), G-protein (GTP␥S), and AC catalytic unit with forskolin (Fsk). *PϽ0.01, nϭ5. B, Effects of carbachol on AC activity. AC was preactivated by ISO. AC activity was then determined in the absence and presence of carbachol. Carbachol at 10 mol/L produced its maximal inhibitory effect. *PϽ0.01, nϭ5. C, To investigate the inhibition of AC activity by Ca 2ϩ , we examined cAMP production in membranes from the hearts of WT and AC5 Ϫ/Ϫ at increasing Ca 2ϩ concentrations in the presence of ISO. ISO-stimulated AC activity was inhibited more in WT than in AC5 Ϫ/Ϫ . The value at 0.08 mol/L free Ca 2ϩ was taken as 100%. *PϽ0.05 using ANOVA for all data points except 1.7 mol/L. 
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␤-AR Binding Assay and Western Blotting
The expression of ␤-AR was not different (Kd: WT 102Ϯ17 pmol/L, AC5 Ϫ/Ϫ 115Ϯ29 pmol/L; Bmax: WT 36Ϯ5 fmol/mg, AC5 Ϫ/Ϫ 31Ϯ4 fmol/mg; nϭ5, PϭNS), nor was the expression of Gs␣, Gi␣, Gq␣, G␤␥, ␤-ARK, ␣ 1 -AR, or muscarinic receptor type 2 ( Figure 6A ).
K ؉ Current Activity
To determine whether enhanced baseline HR and blunted response to muscarinic agonists in AC5 Ϫ/Ϫ are attributable to changes in the K ϩ channel, we examined muscarinic receptor-coupled K ϩ channel currents in atrial myocytes. 30, [33] [34] [35] [36] Figure 6B shows representative atrial K ϩ channel currents induced by carbachol (10 mol/L) recorded in WT and AC5 Ϫ/Ϫ myocytes. Rapid application of carbachol elicited an outward K ϩ current via Gi proteins. The carbachol-induced currents rose quickly to a peak and then decayed slowly to a steady level. The peak amplitude and decay time were similar between WT and AC5 Ϫ/Ϫ myocytes ( Figure 6C ). These results indicate that coupling between muscarinic receptors and the Gi-gated K ϩ channel is not altered in AC5 Ϫ/Ϫ myocytes.
Basal Ca 2؉ Channel Activity and Response to ISO
Peak inward I Ca amplitude (with 5 mmol/L EGTA in the pipette solution), normalized to cell capacitance (I Ca density), was similar in myocytes isolated from AC5 Ϫ/Ϫ (7.1Ϯ0.3 pA/pF, nϭ69) and WT (6.7Ϯ0.3 pA/pF, nϭ55). Half decay time of I Ca at ϩ10 mV was 21.9Ϯ1.4 and 21.0Ϯ1.4 ms for AC5 Ϫ/Ϫ and WT, respectively. These data suggest that changes in AC activity did not directly influence Ca 2ϩ channel density or inactivation kinetics. In previous studies, we have proposed that AC activity and subsequent cAMP synthesis, which modulate Ca 2ϩ channel activity, are regulated by Ca 2ϩ influx through the channel. 20, 37 We thus compared the effects of ISO on I Ca using procedures designed to modulate the cytoplasmic Ca 2ϩ concentration with two different Ca 2ϩ chelators, EGTA and BAPTA, the latter of which have faster Ca 2ϩ binding kinetics, and with the use of extracellular barium (Ba 2ϩ ), which permeates the Ca 2ϩ channel but does not trigger Ca 2ϩ of the sarcoplasmic reticulum (SR). Figure 7A shows a typical example of the effect of ISO (1 mol/L) on I Ca in WT and AC5 Ϫ/Ϫ . In both groups, ISO increased the current amplitude at all test potentials and also shifted the I-V relationships toward more negative potentials. However, in the presence of ISO, peak I Ca amplitude in AC5 Ϫ/Ϫ . *PϽ0.01, nϭ5. C, Baroreflex regulation of HR. Baroreflex slowing of HR in response to phenylephrineinduced increase in arterial pressure is shown by the plot of systolic arterial pressure (SAP) versus the inverse of heart rate, ie, the R-R interval (ms). The depressed slope indicates that reflex parasympathetic bradycardia was impaired in AC5 Ϫ/Ϫ . Figure 6 . A, Western blot analysis for protein expression of Gs␣, Gi␣, Gq␣, G␤, G␥, and ␤-adrenergic receptor kinase (␤-ARK) as well as ␣ 1 -AR and muscarinic receptor type 2 (mAChR) in WT and AC5 Ϫ/Ϫ . There were no differences in any of these proteins in AC5 Ϫ/Ϫ . B, Carbachol-activated K ϩ current in atrial myocytes isolated from WT and AC5 Ϫ/Ϫ . The cells are held at Ϫ40 mV, and carbachol was applied as indicated in the bar above each trace. C, Mean carbachol-induced current density. Peak outward K ϩ currents were normalized to cell capacitance to yield current density (pA/pF). Data are meanϮSEM of WT (nϭ27) and AC5 Ϫ/Ϫ (nϭ16) cells.
dialyzed with EGTA (Ϸ1.7-fold), suggesting that Ca 2ϩ inhibited Ca 2ϩ channel activity in WT. 20 In contrast, the responses of AC5 Ϫ/Ϫ myocytes to ISO were essentially the same in all three conditions (Ϸ1.5-fold), suggesting that Ca 2ϩ -mediated inhibition of Ca 2ϩ channel activity was markedly diminished in AC5 Ϫ/Ϫ . These results suggest that intracellular Ca 2ϩ can inhibit ␤-AR-mediated activation of Ca 2ϩ channels, presumably through directly inhibiting cardiac AC activity, 20 and that type 5 AC is a major target of this inhibition ( Figure 7B ).
Discussion
We developed a mouse model with disruption of a major AC isoform (type 5) in the heart. It was predictable that increases in cardiac function in response to ISO would be diminished in AC5 Ϫ/Ϫ , as was demonstrated in this study. Indeed, the decrease in cardiac responsiveness to ISO in vivo paralleled the data in vitro on AC activity. Because overexpression of type 5 AC in the heart enhanced cardiac function, 11 we had expected that baseline cardiac function and HR would be reduced in AC5 Ϫ/Ϫ , which was not observed. Despite the decrease in AC activity, basal cardiac function and HR were not decreased in AC5 Ϫ/Ϫ . Actually, HR was significantly elevated in conscious AC5 Ϫ/Ϫ . Although we do not know all the mechanisms that contribute to the increase in cardiac rate, we propose at least three mechanisms that are impaired in AC5 Ϫ/Ϫ : muscarinic inhibition of AC activity, baroreflex restraint of HR, and Ca 2ϩ -mediated inhibition of AC activity. Because the elevated HR was not likely attributable to enhanced sympathetic tone, ie, sympathetic responses were attenuated in AC5 Ϫ/Ϫ in both in vivo and in vitro experiments, we hypothesized that it was attributable, at least in part, to the loss of parasympathetic inhibition, because type 5 AC is a major Gi-inhibitable isoform in the adult heart. 17, 18 To confirm this, we demonstrated that muscarinic stimulation, which inhibits cardiac function and HR, was attenuated in AC5 Ϫ/Ϫ both in the presence and absence of enhanced ␤-AR stimulation with ISO. Conversely, atropine increased HR in WT but not in AC5 Ϫ/Ϫ , supporting the concept that the higher baseline HR was attributable to the loss of parasympathetic restraint. Furthermore, we demonstrated that arterial baroreflex slowing of HR, which occurs through parasympathetic nerves, was also blunted in AC5 Ϫ/Ϫ . Therefore, at any given arterial pressure, there is less baroreflex restraint, resulting in elevated HR. Taken together, these data provide convincing evidence in vivo that type 5 AC exerts a major role in parasympathetic regulation of cardiac function in addition to its key role in sympathetic regulation, which has been recognized for some time. Thus, AC-mediated parasympathetic modulation of ventricular function and atrial function, ie, HR, must be considered along with the more widely recognized mechanisms involving muscarinic modulation of K ϩ channel activity 30, 38 and muscarinic regulation at the level of membrane receptors, or Gi. To support this conclusion, the K ϩ current in atrial myocytes and the expression of G proteins, ␤-ARK, muscarinic receptor type 2, and ␤-and ␣ 1 -AR were not altered in AC5 Ϫ/Ϫ . Finally, it is also conceivable that the impaired Ca 2ϩ inhibition of AC also contributes to the increased HR at baseline. To conclude that tachycardia in AC5 Ϫ/Ϫ was attributable to the loss of parasympathetic restraint, it is important to rule out the possibility that some other compensatory pathway did not cause the tachycardia. This possibility is unlikely for several reasons. First, the increase in HR is not compensatory but is actually opposite the prediction that reduced contractility and HR would be expected from disruption of AC. Although unlikely, it is still possible that the resetting autonomic activity in the brain, or some mechanism at the level of Ca 2ϩ channels, could be involved. Type 5 AC is also located in the striatum of the brain, and disrupting this isoform of AC does alter dopaminergic transmission in the brain. 39, 40 However, it is more likely that parasympathetic stimulation leads to activation of muscarinic receptors and Gi to inhibit type 5 AC in the heart, which results in restraint on baseline HR. In the absence of type 5 AC, this restraint is lost and HR rises, as we observed in the AC5 Ϫ/Ϫ mice in this investigation. It is important to note that the bradycardia resulting from pharmacologic muscarinic inhibition with ACh was attenuated in AC5 Ϫ/Ϫ , indicating that the mechanism is localized to the heart and does not reside in the CNS. In additional support of this conclusion are the complementary in vitro data from cardiac membranes. HR is thought to be regulated at the level of the muscarinic receptor, or Gi, or GIRK. 36 In the present investigation, coupling between muscarinic receptors and GIRK was not altered in AC5 Ϫ/Ϫ . In view of the major alteration in muscarinic control in AC5 Ϫ/Ϫ , we conclude that cardiac rate of contractility is also regulated at the level of AC. In support of this concept, a recent study suggested that muscarinic inhibition of ␤ 1 -AR stimulation may occur at the level of cAMP 41 and that ␤ 1 -AR and type 5 AC are located in the same subcellular fraction. 42 In cardiac muscle, Ca 2ϩ influx through the L-type Ca 2ϩ channel is the primary pathway for initiation and maintenance and for the modulation of contractility by catecholamines. The increase in I Ca by the ␤-adrenergic agonist ISO occurs via a cascade of events leading to protein kinase A-mediated phosphorylation of components associated with the Ca 2ϩ channel. In turn, cardiac AC is regulated negatively by low concentrations of Ca 2ϩ . 19, 20 This mechanism was also impaired in AC5 Ϫ/Ϫ . The extent to which this mechanism is impaired in AC5 Ϫ/Ϫ must be interpreted cautiously, because small changes in experimental conditions can influence the magnitude of the results. Our finding suggested that under physiological conditions, an increase in Ca 2ϩ entry and inhibition of type 5 AC, leading to decreased phosphorylation and thus activity of the Ca 2ϩ channel, can work synergistically to provide an intrinsic feedback mechanism for cellular Ca 2ϩ homeostasis. Thus, because of the lack of Ca 2ϩ -inhibitable type 5 AC in AC5 Ϫ/Ϫ , this negative feedback inhibition of the L-type Ca 2ϩ channel may be lost. This loss may account for, at least in part, the maintained cardiac function in AC5 Ϫ/Ϫ . It is also important to consider the possibility that differences in SR loading and Ca 2ϩ handling may have affected the response to ISO. However, in previous studies, 20, 37 we found in mouse ventricular myocytes that AC activity and subsequent cAMP synthesis, which modulate Ca 2ϩ channel activity, are regulated by the Ca 2ϩ entering through the Ca 2ϩ channel rather than by Ca 2ϩ released from the SR stores.
Another consideration is potential changes in calmodulin levels, which could regulate Ca 2ϩ -dependent Ca 2ϩ channel inactivation. 43 However, AC5 Ϫ/Ϫ mice did not exhibit changes in Ca 2ϩ channel amplitude or inactivation time course. Furthermore, calmodulin content assessed by Western blotting did not change in the AC5 Ϫ/Ϫ (data not shown). In summary, because type 5 AC is the major AC isoform expressed in the adult mouse heart, it was surprising to find no effect on baseline cardiac function but rather an increase in HR despite reduced baseline AC activity. Both the increased basal HR and blunted baroreflex-mediated bradycardia may be related to a loss of parasympathetic restraint and reduced Ca 2ϩ regulation of AC. Other mechanisms, not yet identified, may also play a role in mediating these results. Thus, type 5 AC regulates cardiac inotropy and chronotropy through the parasympathetic arm of the autonomic nervous system as well as through the sympathetic arm. Therefore, these new mechanisms for regulation of parasympathetic/sympathetic interactions and Ca 2ϩ -mediated regulation conveyed by this specific AC isoform in the heart will likely have broad significance for the understanding of the pathophysiology and treatment of heart failure as well as in normal cardiac regulation.
ONLINE DATA SUPPLEMENT Expanded Materials and Methods
Generation of Knockout Mice
The targeting construct was prepared by ligating a 2. 
Radioligand Binding Assays and Western Blotting
Radioligand binding assays for β-AR were conducted using the above membrane preparations and 125 I-cyanopindolol as previously described 2 . Western blotting for type 5 AC, Gsα, Giα, Gqα, Gβγ, β 1 -adrenergic receptor (β 1 -AR), β-adrenergic receptor kinase (β-ARK), and muscarinic receptor type 2 were conducted using either the membrane preparation or whole tissue homogenates. Western blotting was conducted using commercially available antibodies, except for type 5 AC antiserum, which was raised against the 27-mer amino acids (NH2-IGHNPPHWGAERPFYNHLGGNQVSKEC-COOH) that was obtained from the C1b domain of AC5 (amino acid residues 638-662). This sequence is conserved among different animal species but shows a very low sequence homology (14.8%) to the corresponding domain of the type 6 AC (kindly provided by Dr. James E Tomlinson, Millennium Pharmaceuticals Inc., Cambridge, MA). Because of its high specificity to type 5 AC, it does not cross react to type 6 AC. Accordingly, AC5 -/-showed a null, not reduced, expression of type 5 AC.
Electrophysiological Studies
Whole-cell currents were recorded using patch-clamp techniques as previously described [3] [4] [5] [6] . Cell capacitance was measured using voltage ramps of 0.8 V/s from a holding potential of -50 mV. All experiments were performed at room temperature. 
